Meyers Michael L. 4
4 · Syndax Pharmaceuticals Inc · Filed Apr 28, 2021
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Purchase
Common Stock
2021-04-26$15.46/sh+500$7,730→ 15,666 total
4 · Syndax Pharmaceuticals Inc · Filed Apr 28, 2021
Common Stock